Results 161 to 170 of about 49,566 (218)

Serum HBsAg and HBeAg levels are associated with liver pathological stages in the immune clearance phase of hepatitis B virus chronic infection.

Molecular Medicine Reports, 2015
D. Zeng, Yu-Rui Liu, Jing Dong, Yueyong Zhu, You-bing Li, Jing Chen, Q. Zheng, Jiaji Jiang   +7 more
semanticscholar   +1 more source

Absence of steatosis combined with cardiometabolic risk factors confers the highest hepatocellular carcinoma risk in treated chronic hepatitis B. [PDF]

Ann Med
Wang HW, Lai HC, Hsu WF, Chen SH, Kuo YC, Peng CY.   +5 more
europepmc   +1 more source

Antiviral treatment response to nucleos(t)ide analogues in chronic hepatitis B patients with normal alanine aminotransferase levels: a retrospective multi-center study. [PDF]

Emerg Microbes Infect
Cao F, Wang J, Xiong Y, Zhang Y, Zhang X, Fan T, Zhu L, Zhang S, Zhang Z, Pan Y, Li Y, Jiang C, Xia J, Shi Y, Yan X, Chen Y, Liu X, Zhu C, Wu C, Huang R.   +19 more
europepmc   +1 more source

Adaptive Evolution and Distinct Mutation Signatures of Full-Length HBV Quasispecies in HBeAg-Negative Chronic Hepatitis B. [PDF]

Microbiologyopen
Wu C, Liu F, Li X, Li X, Li H, Zhang S, Yan X, Zhou T, Wei J.   +8 more
europepmc   +1 more source

Hepatitis B virus seromarkers as an unmet need for screening among patients in North India. [PDF]

J Family Med Prim Care
Irfan S, Kumar P, Seema K.
europepmc   +1 more source

Hepatitis B Virus e Antigen in Mother-to-Child Transmission and Clinical Management of Hepatitis B. [PDF]

Viruses
Ning Q, Ou JJ.
europepmc   +1 more source

HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patients. [PDF]

BMC Gastroenterol
Xie Y, Zhang X, Yang X, Zheng S, Zhang S, Zhang X, Kang H, Duan X, Cai W, Yin P, Ma X, Liu J, Lu F, Dai L, Feng B.   +14 more
europepmc   +1 more source

Efficacy and safety of PEG-IFN α-2b and tenofovir amibufenamide in combination therapy for chronic hepatitis B. [PDF]

BMC Infect Dis
Zhao W, Li L, Liu S, Zhang W, Gao Y, Zhao Z, Liu X, Luo Y, Li D, Liu C.   +9 more
europepmc   +1 more source